Skip to main content
SpringerLink
Log in

Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We investigated the potential of chronic administration of an oral daily dose (10 mg/kg) of the dietary flavonoid quercetin to prevent hypertension and oxidative stress induced by deoxycorticosterone acetate (DOCA)-salt in rats. We have compared its effects to those produced by the well-known anti-hypertensive drug verapamil, administered orally (20 mg/kg/day). Quercetin and verapamil treatments reduced systolic blood pressure of DOCA-salt rats in approximately 67.6 and 63.3% respectively, producing no effect in control animals. Both drugs reduced significantly hepatic and renal hypertrophy induced by DOCA-salt administration, while only quercetin prevented cardiac hypertrophy. Decreased endothelium-dependent relaxation to acetylcholine of aortic rings from DOCA-salt-treated rats was improved by quercetin, but verapamil only enhanced it in the presence of superoxide dismutase (SOD) plus catalase. Increased plasma and heart thiobarbituric acid reactive substances (TBARS) and total glutathione (GSH) levels in liver and heart, decreased liver glutathione peroxidase (GPX) and liver and kidney glutathione transferase (GST) activities were observed in DOCA-salt-treated rats compared to the control animals. The antihypertensive effect of quercetin was accompanied by normalisation of plasma TBARS values, improvement of the antioxidant defences system in heart and liver, restoring total GSH levels in both organs and altered liver GST and GPX activities, and improving kidney GST activity. Verapamil treatment only restored GSH levels in heart, having no effect on other alterations induced by DOCA-salt chronic administration in the antioxidant defences analysed. In conclusion, quercetin shows both antihypertensive and antioxidant properties in this model of mineralocorticoid hypertension, while verapamil exhibits only antihypertensive effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McIntyre M, Bohr DF, Dominiczak AF: Endothclial function in hypertension: The role of superoxide anion. Hypertension 34: 539-545, 1999

    PubMed  Google Scholar 

  2. Lacy F, O'Connor DT, Schmid-Schonbein GW: Plasma hydrogen peroxide production in hypertensives and normotensives subjects at genetic risk of hypertension. J Hypertens 16: 291-303, 1998

    Article  PubMed  Google Scholar 

  3. Russo C, Oliviero O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrucher R: Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267-1271, 1998

    Article  PubMed  Google Scholar 

  4. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003

    Article  PubMed  Google Scholar 

  5. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, Perez de Lema G, Rodriguez-Puyol M, Lamas S, Rodriguez-Puyol D: Role of reactive oxygen species in the signalling cascade of cyclosporine Amediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 1224: 447-454, 1998

    Article  Google Scholar 

  6. Schnackenberg CG, Welch WJ, Wilcox CS: Normalisation of blood pressure and renal vasculature resistance in SHR with a membranepermeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32: 59-64, 1998

    PubMed  Google Scholar 

  7. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, Omata M: Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens 10: 116S-119S, 1997

    PubMed  Google Scholar 

  8. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS: Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388, 2002

    Article  PubMed  Google Scholar 

  9. Hollenberg NK, Coletti C, Passan D: Hypertension, volume and vasoconstriction: studies on the renal blood supply in SHR, WKY and DOCA-salt rat models. Hypertension Res 15: 3-11, 1992

    Google Scholar 

  10. Wu R, Millette E, Lingyun W, de Champlain J: Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 19: 741-748, 2001

    Article  PubMed  Google Scholar 

  11. Somers MJ, Mavromatis K, Galis ZS, Harrison, DG: Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000

    PubMed  Google Scholar 

  12. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC: Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781-786, 2001

    PubMed  Google Scholar 

  13. Nicod L, Rodriguez S, Letang JM, Viollon-Abadie C, Jacqueson A, Berthelot A, Richert L: Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague Dawley rats. Mol Cell Biochem 203: 33-39, 2000

    PubMed  Google Scholar 

  14. Vaziri ND, Wanng XQ, Oveisi F, Rad B: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000

    PubMed  Google Scholar 

  15. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF: Superoxide excess in hypertension and aging: A common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001

    PubMed  Google Scholar 

  16. Shou I, Wang LN, Suzuki S, Fukui M, Tomino Y: Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats. Am J Med Sci 314: 377-384, 1997

    Article  PubMed  Google Scholar 

  17. Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J: Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Brit J Pharmacol 133: 117-124, 2001

    Article  Google Scholar 

  18. Duarte J, Galisteo M, Ocete MA, Pérez-Vizcaíno F, Zarzuelo A, Tamargo J: Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats. Mol Cell Biochem 221: 155-160, 2001

    Article  PubMed  Google Scholar 

  19. Duarte J, Jiménez R, O'Valle F, Galisteo M, Pérez-Palencia R, Vargas F, Pérez-Vizcaíno F, Zarzuelo A, Tamargo J: Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 20: 1843-1854, 2002

    Article  PubMed  Google Scholar 

  20. Gavras H, Brunner HR, Larga JH, Vaughan ED Jr, Koss M, Cote LJ Gavras I: Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: Role of renin and sodium in vascular changes. Circ Res 36: 300-309, 1975

    PubMed  Google Scholar 

  21. Aguas AP, Nickerson PA: Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC). Am J Pathol 110: 48-54, 1983

    PubMed  Google Scholar 

  22. Duarte J, Pérez-Vizcaíno F, Zarzuelo A, Jiménez J, Tamargo J: Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 239: 1-7, 1993

    Article  PubMed  Google Scholar 

  23. Anderson ME: Determination of glutathione and glutathione disulfide in biological samples. Meth Enzymol 113: 548-555, 1985

    PubMed  Google Scholar 

  24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976

    Article  PubMed  Google Scholar 

  25. Flohé L, Günzler WA: Assays of glutathione peroxidase. Meth Enzymol 105: 114-121, 1984

    PubMed  Google Scholar 

  26. Carlberg I, Mannervik B: Glutathione reductase. Meth Enzymol 113: 484-490, 1985

    PubMed  Google Scholar 

  27. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974

    PubMed  Google Scholar 

  28. Zingarelli B, Szabo C, Salzman AL: Blockade of polly(ADP-ribose)-synthetase inhibits neutrophil recruitment, oxidant generation and mucosal injury in murine colitis. Gastroenterology 116: 335-345, 1999

    Article  PubMed  Google Scholar 

  29. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation product: Malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186: 407-421, 1990

    PubMed  Google Scholar 

  30. Griendling KK, Alexander RW: Oxidative stress and cardiovascular disease. Circulation 96: 3264-3265, 1997

    PubMed  Google Scholar 

  31. Givertz MM, Colucci WS: New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress. Lancet 52: SI34-SI38, 1998

    Article  Google Scholar 

  32. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88: 10045-10048, 1991

    PubMed  Google Scholar 

  33. Hoida G, Lindt S, Eichenberger E: The course of blood pressure and organ changes in rats with DOCA-hypertension. Arznim Forsch 26: 2003-2008, 1976

    Google Scholar 

  34. Toth KM, Beehler CJ, Parry SS, Halek MM, Berger EM, Repine JE: Erythrocyte antioxidants as scavengers and/or indicators of oxygen metabolites in biological systems. In: G. Rotilio (ed). Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine. Elsevier, Amsterdam, 1986, pp 391-394

    Google Scholar 

  35. Binda D, Nicod L, Viollon-Abadie C, Rodriguez S, Berthelot A, Coassolo P, Richert L: Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat and effect of hypertension (SHR, DOCA). Ex vivo and in vitro data. Mol Cell Biochem 218: 139-146, 2001

    Article  PubMed  Google Scholar 

  36. Nicod L, Rodriguez S, Jacqueson A, Viollon-Abadie C, Berthelot A, Richert L: Clofibric acid or diethylmaleate supplemented diet decrease blood pressure in DOCA-salt treated male Sprague Dawley rats. Relation with liver antioxidant status. Mol Cell Biochem 213: 65-73, 2000

    Article  PubMed  Google Scholar 

  37. Yuan YV, Kitts DD, Godin DV: Variations in dietary fat and cholesterol intakes modify antioxidant status of SHR and WKY rats. J Nutr 128: 1620-1630, 1998

    PubMed  Google Scholar 

  38. Ma L, Johnson P: Antihypertensive drug therapy and antioxidant enzyme mRNA levels in spontaneously hypertensive (SHR) rats. Comp Biochem Physiol B Biochem Mol Biol 122: 119-126, 1999

    Article  PubMed  Google Scholar 

  39. Rushmore TH, Pickett CB: Glutathione-S-transferases, structure, regulation, and therapeutic implications. J Biol Chem 268: 11475-11478, 1993

    PubMed  Google Scholar 

  40. Carlos DM, Goto S, Urata Y, Iida T, Cho S, Niwa M, Tsuji Y, Kondo T: Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart. Free Radic Res 29: 143-150, 1998

    PubMed  Google Scholar 

  41. Perna AF, Smogorzewski M, Massry SG: Effects of verapamil on the abnormalities in fatty acid oxidation of myocardium. Kidney Int 36: 453-457, 1989

    PubMed  Google Scholar 

  42. Selloum L, Reichl S, Müller M, Sebihi L, Arnhold J: Effects of flavonols on the generation of superoxide anion radicals by xanthinc oxidase and stimulated neutrophils. Arch Biochem Biophys 395: 49-56, 2001

    Article  PubMed  Google Scholar 

  43. Hanasaki Y, Ogawa S, Fukui S: The correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Radical Biol Med 16: 845-850, 1994

    Article  Google Scholar 

  44. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C: Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426: 331-336, 1998

    Article  PubMed  Google Scholar 

  45. Inal M, Altinisik M, Bilgin MD: The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 20: 291-296, 2002

    Article  PubMed  Google Scholar 

  46. Mason RP, Mak IT, Trumbore MW, Mason PE: Antioxidant properties of calcium antagonists related to membrane biophysical interactions. Am J Cardiol 84: 16L-22L, 1999

    Article  PubMed  Google Scholar 

  47. Baykal Y, Yilmaz MI, Celik T, Gok F, Rehber H, Akay C, Kocar IH: Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 21: 1207-1211, 2003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Medicine, University of Granada, 18071, Granada, Spain

    Milagros Galisteo, María Francisca García-Saura, Rosario Jiménez, Immaculada Concepión Villar, Antonio Zarzuelo & Juan Duarte

  2. Department of Physiology, School of Medicine, University of Granada, 18071, Granada, Spain

    Félix Vargas

Authors
  1. Milagros Galisteo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María Francisca García-Saura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosario Jiménez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Immaculada Concepión Villar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Zarzuelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Félix Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Juan Duarte
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galisteo, M., García-Saura, M.F., Jiménez, R. et al. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol Cell Biochem 259, 91–99 (2004). https://doi.org/10.1023/B:MCBI.0000021360.89867.64

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000021360.89867.64

Search

Navigation